Was It Vertigo That Sent Me Tumbling the Other Day?
In the four decades I’ve lived with MS, I’d never before experienced a serious case of vertigo. I’ve occasionally felt…
Articles by Ed Tobias
MS News That Caught My Eye Last Week: Myelin Repair, Early DMT Use, Online Physical Therapy, At-home Exercise
Scientists Discover Enzyme Needed for Activating Myelin Repair Here’s encouraging news for those interested in remyelination — and who…
Do High Antibody Levels Mean I’m Protected Against COVID-19?
Is 2,500 my magical COVID-19 number? At my annual MS checkup a week ago, my neurologist included a blood test…
MS News That Caught My Eye Last Week: Stem Cell Trial, Young PWMS and DMTs, Exoskeleton, Tests for Kids
Stem Cell Transplant Trial Enrolls First Patient in Minnesota It looks as if we’re moving closer to the day…
45 Years and Counting, Even With MS
Happy anniversary to us! My wife, Laura, and I are celebrating our 45th wedding anniversary this month. It’s hard to…
MS News That Caught My Eye Last Week: Nasal DMT, VR for Gait, Brain Stimulation, Amino Sugars
Nasal Foralumab Led to Promising Immune Effects in Phase 1 Trial It sure would be nice to have a…
Should Dr. Google Help Guide Your Treatment?
Paging Dr. Google. OK, maybe I’m being overly dramatic, but The Wall Street Journal recently reported that Google and HCA…
How Do You Define an MS Cure?
“Why aren’t researchers doing more to find a cure for multiple sclerosis?” “Why isn’t more effort and money devoted to…
MS News That Caught My Eye Last Week: Zeposia, Music and Gait, Video Therapeutics, Treatment Perceptions
NICE Again Says No to Adding Zeposia to Health System for England and Wales Reading this news, I’m again…
When an Unexpected Driving Test Causes a Pseudo-flare
My tough day started when Brenda asked, “Why do you use that scooter?” Brenda was sitting behind a desk…
MS News That Caught My Eye Last Week: Fatigue, Myelin, Gut Microbes, Bots Promoting Shots
Fatigue Prevalence Remains High in MS Patients Is this a surprise to anyone who has lived with MS for…
Efficacy of Pfizer-BioNTech COVID-19 Vaccine Varies by DMT, Study Finds
Are you being treated with a disease-modifying therapy (DMT) and wondering how it might affect the efficacy of an mRNA-based…
MS News That Caught My Eye Last Week: Early MS, Fenebrutinib, Restless Legs, Safer MRIs
Phase 4 Trial Will Test if Ocrevus Can Prevent MS Onset in RIS Patients Yes, you’re reading this right.
This New Tool Can Help You Choose Which DMT to Use
Sometimes it seems as if people with MS are asked to flip a coin to make what’s arguably the most…
MS News That Caught My Eye Last Week: FDA and Tysabri, COVID-19 and CD20, Gilenya Infections, Therapeutic Lag
FDA Rejects Under-the-skin Tysabri for Relapsing MS I expect this decision will be a disappointment for those who had…
What Do the Oscars and Our COVID-19 Response Have in Common?
What could the Academy Awards and COVID-19 possibly have in common for people with disabilities? Stay tuned, and I’ll tell…
MS News That Caught My Eye Last Week: COVID-19 and Flares, Hiding MS Status, Blood Proteins, Tysabri
#AANAM – COVID-19 Often Leads to Flares in MS Patients, Survey Finds I’ve read more than a few social…
Let’s Treat Older MS Patients With More Respect
As comic Rodney Dangerfield might have said, older people with MS “just don’t get no respect.” By older, I mean…
MS News That Caught My Eye Last Week: Helper T-cells, PML, WNT9B Gene, New MS Subtypes
Helper T-cells Drive Transition from RRMS to SPMS, Study Suggests The T-cells referred to in this study, known as…
My MS Likes It Hot, and Florida’s Just the Place
Many people with MS avoid Florida. I crave it. My wife and I finally returned here in early March, escaping…
MS News That Caught My Eye Last Week: Predicting Progression, DMT Costs, MS Rates
Retinal Layer Thickness May Predict MS Progression, Relapses We all know how unpredictable MS is. For some, it progresses…
An Update on My Lemtrada Journey, 3 Years After Round 2
Where has the time gone? It’s been three years since I completed my second round of Lemtrada (alemtuzumab) infusions.
MS News That Caught My Eye Last Week: Nasal Spray Treatment, Anxiety Management, POMS, PoNS
SPMS Patient First to Be Treated With Antibody Given via Nasal Spray How great is this? As someone who…
Why We Still Need to Wear Masks, Socially Distance, and Wash Our Hands
“I’ve had my shots, so I’m protected,” a friend recently told me, referring to the COVID-19 vaccine. My wife and…
MS News That Caught My Eye Last Week: COVID-19, UK ‘Mega-trial’, Pilates, Rituximab
Certain Factors Worsen Outcomes in MS Patients With COVID-19 The worse your MS disability is, it seems, the worse…
Ocrevus and PML: Should We Be Worried?
The journal JAMA Neurology recently reported that a 78-year-old man with progressive multiple sclerosis died after being diagnosed with…
MS News That Caught My Eye Last Week: Ponvory, Ocrevus, COVID-19 Survey, Ampyra
Ponvory (ponesimod) Approved for Adults With Relapsing Forms of MS Add one more medication to the disease-modifying therapy (DMT)…
The MS Immune System: Suppressed, Compromised, or What?
Lately, I’ve seen a lot of incorrect information on social media about how multiple sclerosis affects our immune system. Some…
MS News That Caught My Eye Last Week: Cure Connections, PIPE-307, Temelimab, EHP-101
NeurologyLive, CMSC Launch Expert Video Series ‘Cure Connections’ This series of 13 videos, designed for healthcare professionals, focuses on…
My 2nd COVID-19 Vaccine Shot Caused No Harsh Side Effects
Last week, my wife and I were back in Bowie, Maryland, for our second shot of the Moderna COVID-19…